new study has found no direct link between antidepressant use during pregnancy and one type of birth defect . newline_char the research , published in today ’ s issue of the new england journal of medicine , comes nine years after the u.s. food and drug administration warned that exposure to selective serotonin reuptake inhibitors — the most commonly prescribed antidepressants — might increase the risk of heart malformations in the developing fetus . story_separator_special_tag wednesday , june 18 , 2014 ( healthday news ) -- antidepressants taken during the first three months of pregnancy do n't appear to increase the risk of heart defects in babies , new research suggests . newline_char " the most critical period in the development of an embryo or in the growth of a particular organ is during the time of most rapid cell division , " said krista huybrechts , lead study author and epidemiologist at the brigham and women 's hospital , in boston . newline_char the team looked at whether antidepressants , including those called selective serotonin reuptake inhibitors , or ssris -- such as paroxetine ( paxil ) and sertraline ( zoloft ) -- are indeed associated with an increased risk of heart defects at birth . newline_char they were able to use demographic information , such as age , income and education , as well as data about all physician services and hospitalizations , including diagnoses , procedures and filled outpatient prescriptions . newline_char women were excluded if they had been treated with drugs that have been associated with birth defects ( such as chemotherapy , lithium , retinoids and thalidomide ) or if their infants had been diagnosed with a genetic abnormality . story_separator_special_tag antidepressant medications the etiologically relevant window for exposure extended from the date of the last menstrual period through day 90 of pregnancy ( first trimester ) .
